Shanghai Fosun Pharmaceutical (Group) Co., Ltd. - 05 Jun 2025 SCHEDULE 13D/A Report for NATURES SUNSHINE PRODUCTS INC Common Stock, no par value (NATR)

Filing Manager
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Reporting Manager
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Security
NATURES SUNSHINE PRODUCTS INC Common Stock, no par value
Symbol
NATR
Shares outstanding
18.4M shares
Disclosed Ownership
2.92M shares
Ownership
15.9%
Form type
SCHEDULE 13D/A
Filing time
09 Jun 2025, 16:30:31 UTC
Date of event
05 Jun 2025
Next filing
27 Jun 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 15.9% 2.92M 2.92M /s/ Yuqing Chen Yuqing Chen / Chairman 0001615258
Fosun Pharma USA Inc. 15.6% 2.85M 2.85M /s/ Yuqing Wang Yuqing Wang / Chief Financial Officer